Post hoc analyses of trials have observed reductions in atrial fibrillation among patients treated with angiotensin-converting enzyme inhibitors(ACEI) or angiotensin receptor blockers(ARBs).

• 近年来,大量研究显示通过抑制肾素-血管紧张素-醛固酮系统可对房颤有一定的预防作用。